Waliszewska-Prosol M, Grandi G, Ornello R, Raffaelli B, Straburzynski M, Tana C
Neurol Ther. 2025; .
PMID: 40085393
DOI: 10.1007/s40120-025-00720-2.
Tian F, Chen Z, Zhang J, Zhang Y, Feng Q
J Epidemiol Glob Health. 2025; 15(1):39.
PMID: 40072651
PMC: 11903986.
DOI: 10.1007/s44197-025-00378-x.
Sic A, Bogicevic M, Brezic N, Nemr C, Knezevic N
Biomedicines. 2025; 13(2).
PMID: 40002876
PMC: 11852498.
DOI: 10.3390/biomedicines13020463.
Cho J, Jo H, Park J, Lee K, Lee H, Kim S
Eur J Clin Pharmacol. 2025; .
PMID: 39994041
DOI: 10.1007/s00228-025-03812-y.
Li M, Huang S, Li J, Hu X, Chen J
Drug Des Devel Ther. 2025; 19:1231-1247.
PMID: 39991088
PMC: 11847418.
DOI: 10.2147/DDDT.S499848.
Low health literacy impact on headache diagnosis.
Pergolizzi Jr J, LeQuang J
Pain Manag. 2025; 15(3):141-147.
PMID: 39987468
PMC: 11881871.
DOI: 10.1080/17581869.2025.2463874.
The quality and reliability of online video resources concerning patient education for migraine treatment in China Mainland: an electronic media-based study.
Ge R, Xu X, Chen Y, You S, Xu J, Dai H
BMC Public Health. 2025; 25(1):656.
PMID: 39966862
PMC: 11834577.
DOI: 10.1186/s12889-025-21861-x.
An analysis of the burden of migraine and tension-type headache across the global, China, the United States, India and Japan.
Xu R, Zhang R, Dong L, Xu X, Fan X, Zhou J
Front Pain Res (Lausanne). 2025; 6:1539344.
PMID: 39963513
PMC: 11830714.
DOI: 10.3389/fpain.2025.1539344.
Physical activity as a predictor of fremanezumab response in chronic migraine - the Phy-Fre-Mig study.
Sierra-Mencia A, Recio-Garcia A, Garcia-Azorin D, de la Torre A, Gonzalez I, Guerrero-Peral A
J Headache Pain. 2025; 26(1):34.
PMID: 39953381
PMC: 11827165.
DOI: 10.1186/s10194-025-01965-w.
Telecoaching and Migraine: Digital Approach to Physical Activity in Migraine Management. A Scoping Review.
Leale I, Di Stefano V, Torrente A, Alonge P, Monastero R, Roccella M
J Clin Med. 2025; 14(3).
PMID: 39941532
PMC: 11818704.
DOI: 10.3390/jcm14030861.
Shared genetic risk and causal associations between Post-traumatic stress disorder and migraine with antithrombotic agents and other medications.
Bainomugisa C, Bruenig D, Sutherland H, Griffiths L, Nyholt D, Mehta D
Neurobiol Stress. 2025; 34:100703.
PMID: 39898008
PMC: 11786899.
DOI: 10.1016/j.ynstr.2024.100703.
Conventional and genetic association between migraine and stroke with druggable genome-wide Mendelian randomization.
Wang X, Pang W, Hu X, Shu T, Luo Y, Li J
Hum Genet. 2025; .
PMID: 39841246
DOI: 10.1007/s00439-024-02725-7.
The epidemiology and unmet need of migraine in five european countries: results from the national health and wellness survey.
Coppola G, Brown J, Mercadante A, Drakeley S, Sternbach N, Jenkins A
BMC Public Health. 2025; 25(1):254.
PMID: 39838307
PMC: 11753071.
DOI: 10.1186/s12889-024-21244-8.
Two Cases of Ischemic Complications in Abdominoplasty After Use of a New Biologic Migraine Medication.
Tuominen R, Koljonen V
Plast Reconstr Surg Glob Open. 2025; 13(1):e6449.
PMID: 39816898
PMC: 11732645.
DOI: 10.1097/GOX.0000000000006449.
Knowledge and Perceptions of Migraine Management and Trigger Factors Among Medical Students in Riyadh, Saudi Arabia: A Cross-Sectional Study.
Alzahrani S, Mulla M, Mulla A, Almegbil I, Alblaihi S, Alkhani O
Cureus. 2025; 16(12):e75666.
PMID: 39803060
PMC: 11725309.
DOI: 10.7759/cureus.75666.
Consistency between headache diagnoses and ICHD-3 criteria across different levels of care.
Overeem L, Ulrich M, Fitzek M, Lange K, Hong J, Reuter U
J Headache Pain. 2025; 26(1):6.
PMID: 39789456
PMC: 11715415.
DOI: 10.1186/s10194-024-01937-6.
Knowledge, attitudes, and practices of migraine management among primary health care physicians in Al-Madinah Al-Munawarah.
Al-Quliti K, Alraddadi A, Alnoaman A, Alahmadi M, Khawaji Z, Alquliti W
J Med Life. 2025; 17(11):1012-1019.
PMID: 39781310
PMC: 11705470.
DOI: 10.25122/jml-2024-0350.
Prevalence, Treatment, and Unmet Needs of Migraine in the Middle East: A Systematic Review.
Alsaadi T, Al Madani A, Alhatou M, Nada M, Albilali A, Al-Qassabi A
Pain Ther. 2024; 14(1):145-183.
PMID: 39738973
PMC: 11751246.
DOI: 10.1007/s40122-024-00686-3.
Epidemiological, clinical characterization and treatment patterns of migraine patients in a Colombian cohort from 2018 to 2022.
Rubio A, Arciniegas J, Bolanos-Lopez J, Gonzalez F, Gomez D, Mesa A
J Headache Pain. 2024; 25(1):226.
PMID: 39719604
PMC: 11667797.
DOI: 10.1186/s10194-024-01918-9.
The Impact of Migraine on the Whole Life Course of Patients: Results from the OVERCOME (Japan) 2nd Study.
Danno D, Suzuki S, Takizawa T, Ishii R, Hamakawa M, Tanizawa Y
Neurol Ther. 2024; 14(1):335-356.
PMID: 39708221
PMC: 11762060.
DOI: 10.1007/s40120-024-00690-x.